PEPTIDES BIO / LABORATORY RECORDS
AOD-9604 in Mouse Models and the WADA hGH Isoform Immunoassay
A source-bound AOD-9604 record separating an obese-mouse and beta3-AR knockout study from the WADA hGH isoform immunoassay record.
Research or raw-material evaluation only. Not for human or veterinary use.
AOD-9604 research material
AOD-9604 5mg is the related catalogue material. The two cited publications concern named experimental records; neither publication identifies a separately received catalogue lot.
Research use only. The cited records describe named experimental systems and do not provide human or veterinary use, dosing, administration, safety, or outcome guidance.
Two AOD-9604 records answer different questions
PMID 11713213 is an in vivo mouse paper. PMID 24124033 is a report titled AOD-9604 does not influence the WADA hGH isoform immunoassay. Their common material term does not make their methods, measurements, or limits interchangeable.
Mouse-model record: obese mice and beta3-AR knockout mice
Heffernan et al. (2001; PMID 11713213) compares human growth hormone and the C-terminal fragment named AOD9604 in obese mice and beta3-adrenergic-receptor knockout mice. The article reports a 14-day mouse experiment, beta3-AR RNA expression, and the authors’ named physiological and lipolysis-related measurements. It also describes a separate acute experiment in the knockout-mouse system.
Those observations belong to the authors’ mouse strains, comparators, timing, and measurements. The paper does not report a receptor-binding experiment, an analytical purity result, or a result for another species, model, or received material lot.
Assay record: WADA hGH isoform immunoassay
Orlovius et al. (2013; PMID 24124033) addresses whether AOD-9604 influences the WADA human-growth-hormone isoform immunoassay. The public record identifies that assay question in the title; it is not a mouse-model paper. The PubMed record is a Letter whose title states the assay question. It does not attribute the mouse-model measurements reported in PMID 11713213 to this immunoassay record.
Keep the source fields with the matching citation
- For PMID 11713213: retain the obese-mouse or beta3-AR knockout context, the hGH and AOD9604 comparators, the reported time frame, and the stated measurements.
- For PMID 24124033: retain the WADA hGH isoform immunoassay as the study question and do not transfer mouse-model measurements to that record.
- For material documentation: retain the received label, lot identifier, receipt date, and supplied documents independently from both publications.
Evidence boundary
Neither cited source establishes the identity, composition, purity, manufacture, or performance of a different catalogue batch. The mouse paper and the immunoassay record can be cited for the specific systems they report; they do not support a claim about a different model or a use recommendation.
References
- Heffernan M et al. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta3-AR knock-out mice. Endocrinology. 2001. PMID 11713213.
- Orlovius AK et al. AOD-9604 does not influence the WADA hGH isoform immunoassay. Drug Test Anal. 2013. PMID 24124033.
Need a product record?
